Rating History for Atara Biotherapeutics (ATRA) by Canaccord

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/8/2026 John Newman Upgrade Buy
(Hold)
13.00
(N/A)
5.15
(10.61)
106.02% Details